𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease

✍ Scribed by Sano, Mary; Ernesto, Christopher; Thomas, Ronald G.; Klauber, Melville R.; Schafer, Kimberly; Grundman, Michael; Woodbury, Peter; Growdon, John; Cotman, Carl W.; Pfeiffer, Eric; Schneider, Lon S.; Thal, Leon J.

Book ID
120204294
Publisher
Massachusetts Medical Society
Year
1997
Tongue
English
Weight
108 KB
Volume
336
Category
Article
ISSN
0096-6762

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The need for levodopa as an end point of
The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and Ξ±-tocopherol
✍ Dr. Peter LeWitt; David Oakes; Lu Cui πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 693 KB

## Abstract Progression of Parkinson's disease (PD) can be detected through changes in clinical ratings or disability assessments. A clinical trial, Deprenyl and Alpha‐Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP), used a novel study end point: increase in parkinsonian disability to th